These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10568898)

  • 1. Equivalence trials in SLE research: issues to consider.
    Kim MY; Buyon JP; Petri M; Skovron ML; Shore RE
    Lupus; 1999; 8(8):620-6. PubMed ID: 10568898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of equivalence trials in showing the usefulness of treatments].
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; de Haan M
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2162-6. PubMed ID: 14626832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).
    Moore AD; Joseph L
    Lupus; 1999; 8(8):612-9. PubMed ID: 10568897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does placebo help establish equivalence in trials of new antidepressants?
    Barbui C; Violante A; Garattini S
    Eur Psychiatry; 2000 Jun; 15(4):268-73. PubMed ID: 10951612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
    Schiffenbauer J; Simon LS
    Lupus; 2004; 13(5):398-405. PubMed ID: 15230299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and analysis of non-inferiority mortality trials in oncology.
    Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
    Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantel-Haenszel-type tests for testing equivalence or more than equivalence in comparative clinical trials.
    Yanagawa T; Tango T; Hiejima Y
    Biometrics; 1994 Sep; 50(3):859-64. PubMed ID: 7981407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conceptual framework for clinical trials in SLE and other multisystem diseases.
    Liang MH; Corzillius M; Bae SC; Fortin P; Esdaile JM; Abrahamowicz M
    Lupus; 1999; 8(8):570-80. PubMed ID: 10568892
    [No Abstract]   [Full Text] [Related]  

  • 13. A confirmatory strategy for therapeutic equivalence trials.
    Kieser M
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):388-90. PubMed ID: 7582393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in planning and interpreting active control equivalence studies.
    Makuch R; Johnson M
    J Clin Epidemiol; 1989; 42(6):503-11. PubMed ID: 2661729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.
    Vavken P
    Clin Orthop Relat Res; 2011 Sep; 469(9):2645-53. PubMed ID: 21246313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial design for ineffectiveness research: a mixed-methods survey.
    Riggs K; Richman J; Kertesz S
    BMJ Evid Based Med; 2020 Aug; 25(4):143-144. PubMed ID: 31757840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical equivalence.
    Bristol DR
    J Biopharm Stat; 1999 Nov; 9(4):549-61. PubMed ID: 10576403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity/equivalence trials for combination vaccines.
    Blackwelder WC
    Ann N Y Acad Sci; 1995 May; 754():321-8. PubMed ID: 7625668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials to assess equivalence: the importance of rigorous methods.
    Jones B; Jarvis P; Lewis JA; Ebbutt AF
    BMJ; 1996 Jul; 313(7048):36-9. PubMed ID: 8664772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.